IDENTIFY Study: Natural History of Maternal Neoplasia
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Study ID
- NCT04049604
- Status
- Recruiting
Conditions
- Maternal Neoplasia
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- NIPT — DEVICEnoninvasive prenatal testing
Study Details
Background: Pregnant women can get a DNA analysis of their blood. The test tells a woman and her doctor about the DNA of her unborn baby. But some women get test results that are abnormal or not reportable. Researchers want to learn more about the relationship between these test results and cancer. Objective: To better understand prenatal DNA test results and how they can predict cancer, if present, in pregnant women. Eligibility: Women 18 and older who got prenatal DNA test results that were abnormal or not reportable and suggested the abnormality was in the woman and not her baby. Design: Potential participants will be screened by phone or in person. They will talk about their medical history and send copies of their medical records. Eligible participants will have a physical exam and medical history. They will give blood and stool samples. They may have a Pap smear. They will talk to a specialist about the test results they got when they were pregnant. Participants will have magnetic resonance imaging (MRI). They will lie on a table that slides in and out of a metal tube, taking pictures. Participants will complete a paper or electronic survey. It will assess their emotional well-being. Participants will get a list of any possible diagnoses and treatment options. Participants may be followed for up to 5 years. They may give blood samples and copies of their medical records. This can be done without traveling to the NIH. In some cases, people might come back to the NIH in one year to see if anything has changed.
Key Dates
- Start date
- Dec 23, 2019
- Status verified
- Feb 2026
- Primary completion
- Apr 30, 2029
- Completion
- Apr 30, 2029
Study Design
- Enrollment
- 365 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Other: 1Women with prenatal testing results that suggest an incidental detection of maternal neoplasia
Primary Outcome Measure
To study the natural history of women with prenatal testing results that suggest an incidental detection of maternal neoplasia [ Time Frame: 5 years ]
Central Contacts
- Amy E Turriff(301) 402-5421
- Benjamin D Solomon, M.D.(301) 402-8824
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 |